Submission Details
| 510(k) Number | K113437 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 21, 2011 |
| Decision Date | August 06, 2012 |
| Days to Decision | 259 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K113437 is an FDA 510(k) clearance for the ACE HEMOGLOBIN ALC(HBALC) REAGENT, ACE CEDIA T UPTAKE REAGENT, ACE T4 REAGENT, ACE FERRITIN REAGENT, a Assay, Glycosylated Hemoglobin (Class II — Special Controls, product code LCP), submitted by Alfa Wassermann Diagnostic Technologies, Inc. (West Caldwell, US). The FDA issued a Cleared decision on August 6, 2012, 259 days after receiving the submission on November 21, 2011. This device falls under the Chemistry review panel. Regulated under 21 CFR 864.7470.
| 510(k) Number | K113437 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 21, 2011 |
| Decision Date | August 06, 2012 |
| Days to Decision | 259 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | LCP — Assay, Glycosylated Hemoglobin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.7470 |